Eli Lilly Urges 9th Circ. Not To Revive Cymbalta Suit

Law360, New York (August 23, 2016, 3:32 PM EDT) -- Eli Lilly and Co. on Monday urged the Ninth Circuit to affirm the denial of class certification and an injunction sought by three consumers accusing the pharmaceutical giant of failing to warn them of antidepressant Cymbalta's withdrawal risk.

Dr. Melissa Strafford, Carol Jacquez and David Matthews Jr. had argued in June that a California federal judge abused his discretion by ordering them to move for certification on their consumer protection law claims in four states without discovery, only to then turn around and conclude the consumers...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Melissa Strafford, et al v. Eli Lilly and Company


Case Number

15-56808

Court

Appellate - 9th Circuit

Nature of Suit

4190 Other Contract Actions

Date Filed

November 24, 2015

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.